Xiao Shen
CEO
Canton Biologics Co., Ltd.
Guangzhou, China
My organisation
About me
Bioprocessing professional and biotech entrepreneur with experience spanning academic research and industrial biologics development.
Holds a PhD from EPFL (École Polytechnique Fédérale de Lausanne), Switzerland, with research focused on cell culture and bioprocessing technologies. Subsequently gained industry experience at ExcellGene SA, working on CHO cell line development and upstream bioprocess platforms.
Founder and CEO of Canton Biologics, a biologics CDMO established in 2016 to support global biopharmaceutical partners with scalable and efficient development and manufacturing solutions.
Professional interests include biologics manufacturing technologies, scalable cell culture systems, and international collaboration in the biopharmaceutical industry.
Additional questions
Interests
What is your primary goal for attending this event?
Speaker sessions (1)
Wednesday, 20 May 2026
14:00 - 14:45
Masterclass 4: A High-Titer CHO Cell-Based Integrated Platform to Accelerate Veterinary Biologics Development
This session presents an integrated CHO-based platform for veterinary biologics, enabling efficient development and scalable manufacturing of recombinant proteins and vaccines while reducing costs and supporting broader adoption in animal health.
Sign-ups available from 1 Apr 2026, 00:00 to 20 May 2026, 14:45